ES371256A1 - Un procedimiento para la preparacion de una vacuna multiva-lente. - Google Patents

Un procedimiento para la preparacion de una vacuna multiva-lente.

Info

Publication number
ES371256A1
ES371256A1 ES371256A ES371256A ES371256A1 ES 371256 A1 ES371256 A1 ES 371256A1 ES 371256 A ES371256 A ES 371256A ES 371256 A ES371256 A ES 371256A ES 371256 A1 ES371256 A1 ES 371256A1
Authority
ES
Spain
Prior art keywords
viruses
translation
preparation
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES371256A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES371256A1 publication Critical patent/ES371256A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0015—Combination vaccines based on measles-mumps-rubella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES371256A 1968-09-11 1969-09-05 Un procedimiento para la preparacion de una vacuna multiva-lente. Expired ES371256A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75923768A 1968-09-11 1968-09-11

Publications (1)

Publication Number Publication Date
ES371256A1 true ES371256A1 (es) 1972-04-01

Family

ID=25054907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES371256A Expired ES371256A1 (es) 1968-09-11 1969-09-05 Un procedimiento para la preparacion de una vacuna multiva-lente.

Country Status (10)

Country Link
AT (1) AT291440B (es)
BE (1) BE738674A (es)
BR (1) BR6912333D0 (es)
DE (1) DE1944956A1 (es)
ES (1) ES371256A1 (es)
FR (1) FR2017790A1 (es)
IE (1) IE33311B1 (es)
IL (1) IL32922A (es)
NL (1) NL6913032A (es)
ZA (1) ZA695453B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633518B1 (fr) * 1988-06-30 1991-03-22 Merieux Inst Procede de stabilisation des vaccins et associations de vaccins a virus attenues conserves sous forme lyophilisee, et compositions obtenues

Also Published As

Publication number Publication date
IE33311B1 (en) 1974-05-15
IL32922A (en) 1973-01-30
NL6913032A (es) 1970-03-13
BR6912333D0 (pt) 1973-04-12
ZA695453B (en) 1971-03-31
BE738674A (es) 1970-03-10
IL32922A0 (en) 1969-11-30
DE1944956A1 (de) 1970-03-19
FR2017790A1 (en) 1970-05-22
AT291440B (de) 1971-07-12
IE33311L (en) 1970-03-11

Similar Documents

Publication Publication Date Title
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
DK361875A (da) Peptider med sterk lh-rh/fsh/rh-virkning og fremgangsmade til deres fremstilling
IT7912799A0 (it) Perfezionamenti nei dispositivi adibiti al dosaggio per aspirazione diprodotti anche finemente polverizzati
GB960850A (en) Measles virus vaccine
ES371256A1 (es) Un procedimiento para la preparacion de una vacuna multiva-lente.
ES258463A1 (es) Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis
GR36834B (el) Μεθοδος και συνθεσεις δια την εισαγωγην αλκοξυβενζαμιδης εις το κυκλοφορικον συστημα.
GB1401565A (en) Vaccine for neonatal calf diarrhoea
PT65737A (en) Voir,s.v.p.,le papier ci joint avec le titre "process for the preparation of disubstituted phenol ethers of 3-amino-2-hydroxypropane,with cerebrovascular activity,application of same for the preparation of pharmaceutical compositions with cerebrovascular activity and application of these pharmaceutical compositions in the treatment of cerebrovascular insufficiency"
ES446637A1 (es) Procedimiento para la preparacion de vacunas acelulares.
ES331077A1 (es) Procedimiento para preparar una vacuna.
SE7513298L (sv) Diaryloxi-imidazolyl-o,n-acetaler till anvendning som lekemedel och sett for deras framstellning
GB949400A (en) Poliomyelitis vaccines
GB949399A (en) Poliomyelitis vaccines
ES182147U (es) Conjunto de cortinas y varillas.
ES287586A1 (es) Un procedimiento para la preparación de una composición terapéutica
ES321833A1 (es) Procedimiento para la obtencion de una vacuna contra el moquillo
GR35526B (el) Μεθοδος παρασκευης ετεροκυκλικων ενωσεων αζωτου.
DK129414B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer eller fysiologisk uskadelige salte deraf med baser.
FI40401C (fi) Menetelmä kestävien, suun kautta nautittavien poliomyelitisvirus-preparaattien valmistamiseksi
ES371843A1 (es) Procedimiento para la preparacion de una vacuna.
BE585993A (fr) Compositions therapeutiques comprenant un vaccin de bacterie, de ricketsie ou de virus, ainsi que leur préparation.
ES279927A1 (es) Procedimiento de preparaciën de una vacuna contra la fiebre aftosa
GB1323842A (en) Immunizing vaccine for the immunization of dogs against kennel cough
ES156189U (es) Muñeco perfeccionado.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19920208